O'Shaughnessy Asset Management’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
CC
EAM
OCA
AG
O'Shaughnessy Asset Management's CRDF Position: Q4 2021 in Review
O'Shaughnessy Asset Management sold out of Cardiff Oncology (CRDF) in Q4 2021, closing a stake of 972 shares — an estimated $6K sold.
O'Shaughnessy Asset Management first reported a position in CRDF in Q4 2020 and held it in 4 quarters. The position peaked at $10K in Q1 2021. 87 funds tracked by Wall St. Rank hold CRDF as of Q4 2021.
- O'Shaughnessy Asset Management reported no remaining Cardiff Oncology position as of Q4 2021 after selling out during the quarter.
- O'Shaughnessy Asset Management sold 972 Cardiff Oncology shares in Q4 2021, an estimated $6K.
- O'Shaughnessy Asset Management first reported a position in Cardiff Oncology in Q4 2020 and held it in 4 quarters.
- O'Shaughnessy Asset Management's Cardiff Oncology position peaked at $10K in Q1 2021.
- 87 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2021.
Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.